SCHEMBL7701648

SCHEMBL7701648

Cc1cccc(Sc2ccccc2C(=O)N[C@H]2CN3CCC2CC3)n1

nearest known ligand 0.59

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HTR3A P46098 5/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6880698 0.82 CHRNA7 (0.67) HTR3A
SCHEMBL7686167 0.78 CHRNA7 (0.51) HTR3A
SCHEMBL5268531 0.78 HTR3A (0.61) HTR3A
SCHEMBL7644363 0.77 CHRNA7 (0.51)
SCHEMBL7601725 0.77 HTR3A (0.52) HTR3A
SCHEMBL7438039 0.76
SCHEMBL7695932 0.76 CHRNA7 (0.53)
SCHEMBL7692924 0.75 CHRNA7 (0.49) HTR3A
SCHEMBL14027668 0.74 HTR3A (0.52) HTR3A
SCHEMBL7438929 0.74 TAS1R3 (0.59)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002016357-A2 QUINUCLIDINE-SUBSTITUTED ARYL MOIETIES FOR TREATMENT OF DISEASE (NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS) PHARMACIA & UPJOHN COMPANY (US) 2002-02-28 WO disclosed